Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Capstone Clinical Research
mi
from
Libertyville, IL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Baber Research Group
mi
from
Naperville, IL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pedia Research, LLC
mi
from
Newburgh, IN
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pedia Research, LLC
mi
from
Newburgh, IN
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Psychiatric Associates
mi
from
Overland Park, KA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pedia Research LLC
mi
from
Owensboro, KY
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pedia Research LLC
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Neurobehavioral Medicine Group, Clinical Trials Division
mi
from
Bloomfield Hills, MI
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Neurobehavioral Medicine Group, Clinical Trials Division
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Trials group at the Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Trials group at the Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
IPS Research Company
mi
from
Oklahoma City, OK
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
BioBehavioral Research of Austin
mi
from
Austin, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Bayou City Research, Ltd.
mi
from
Houston, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Houston Clinical Trials, LLC
mi
from
Houston, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Road Runner Research
mi
from
San Antonio, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Richarmond Behavioral Associates
mi
from
Staten Island, NY
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Richarmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Cyn3rgy Research
mi
from
Gresham, OR
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Elite Clinical Trials
mi
from
Wildomar, CA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Elite Clinical Trials
mi
from
Wildomar, CA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
St. Charles Psychiatric Associates - Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
AVIDA, Inc.
mi
from
Newport Beach, CA
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
AVIDA, Inc.
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Meridien Research
mi
from
Bradenton, FL
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Bayou City Research, Ltd.
mi
from
Houston, TX
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated:  1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated: 1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated:  1/8/2018
University of North Carolina Hospitals - Meadowmont
mi
from
Chapel Hill, NC
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated: 1/8/2018
University of North Carolina Hospitals - Meadowmont
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated:  1/8/2018
Duke University Medical Center - Center for Living
mi
from
Durham, NC
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated: 1/8/2018
Duke University Medical Center - Center for Living
mi
from
Durham, NC
Click here to add this to my saved trials
Attachment Based Family Therapy for Suicidal Adolescents
Attachment Based Family Therapy (ABFT) for Suicidal Adolescents
Status: Enrolling
Updated:  1/8/2018
Drexel University
mi
from
Philadelphia, PA
Attachment Based Family Therapy for Suicidal Adolescents
Attachment Based Family Therapy (ABFT) for Suicidal Adolescents
Status: Enrolling
Updated: 1/8/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Impulsivity and Stimulant Administration
Impulsivity and Stimulant Administration
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Impulsivity and Stimulant Administration
Impulsivity and Stimulant Administration
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Status: Enrolling
Updated:  1/8/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Status: Enrolling
Updated: 1/8/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated:  1/8/2018
Hospital for Special Surgery
mi
from
New York, NY
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated: 1/8/2018
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
PET Imaging in Cocaine Self Administration
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
PET Imaging in Cocaine Self Administration
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Franciscan Skemp Hospital
mi
from
La Crosse, WI
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Franciscan Skemp Hospital
mi
from
La Crosse, WI
Click here to add this to my saved trials
Buspirone as a Candidate Medication for Methamphetamine Abuse
Buspirone as a Candidate Medication for Methamphetamine Abuse
Status: Enrolling
Updated:  1/9/2018
University of Kentucky Medical Center
mi
from
Lexington, KY
Buspirone as a Candidate Medication for Methamphetamine Abuse
Buspirone as a Candidate Medication for Methamphetamine Abuse
Status: Enrolling
Updated: 1/9/2018
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
Status: Enrolling
Updated:  1/9/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
Status: Enrolling
Updated: 1/9/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
Status: Enrolling
Updated:  1/9/2018
Yoga Studio
mi
from
Albuquerque, NM
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
Status: Enrolling
Updated: 1/9/2018
Yoga Studio
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Psychophysiology of Prolonged Exposure for PTSD With/Without Yohimbine
Status: Enrolling
Updated:  1/10/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Psychophysiology of Prolonged Exposure for PTSD With/Without Yohimbine
Status: Enrolling
Updated: 1/10/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
San Francisco Bay Area Center for Cognitive Therapy
mi
from
Oakland, CA
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
San Francisco Bay Area Center for Cognitive Therapy
mi
from
Oakland, CA
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Institute of Living
mi
from
Hartford, CT
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Institute of Living
mi
from
Hartford, CT
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Alexian Brothers Center for Anxiety and OCD
mi
from
Hoffman Estates, IL
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Alexian Brothers Center for Anxiety and OCD
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Kansas City Center for Anxiety Treatment, P.A.
mi
from
Overland Park, KA
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Kansas City Center for Anxiety Treatment, P.A.
mi
from
Overland Park, KA
Click here to add this to my saved trials
CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated:  1/10/2018
Regional Network of Programs, Inc.
mi
from
Bridgeport, CT
CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated: 1/10/2018
Regional Network of Programs, Inc.
mi
from
Bridgeport, CT
Click here to add this to my saved trials